Table 3.

KEGG pathway enrichment analysis.

ID	Description	Gene Ratio	Bg Ratio	P value	p. adjust	Q value
hsa04151	PI3K-Akt signaling pathway	13/47	354/8108	6.15E-08	1.08E-05	7.38E-06
hsa04510	Focal adhesion	9/47	201/8108	1.78E-06	0.000156783	0.000106897
hsa04512	ECM-receptor interaction	6/47	88/8108	1.03E-05	0.000606736	0.000413683
hsa04933	AGE-RAGE signaling pathway in diabetic complications	6/47	100/8108	2.16E-05	0.000864446	0.000589395
hsa00140	Steroid hormone biosynthesis	5/47	61/8108	2.46E-05	0.000864446	0.000589395
hsa05222	Small cell lung cancer	5/47	92/8108	0.000177551	0.005101481	0.003478283
hsa04913	Ovarian steroidogenesis	4/47	51/8108	0.000202900	0.005101481	0.003478283
hsa04010	MAPK signaling pathway	8/47	294/8108	0.000248934	0.005476545	0.003734008
hsa01521	EGFR tyrosine kinase inhibitor resistance	4/47	79/8108	0.001083577	0.021189959	0.014447699
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/47	89/8108	0.001688007	0.028011339	0.019098640
hsa04658	Th1 and Th2 cell differentiation	4/47	92/8108	0.001907410	0.028011339	0.019098640
hsa04657	IL-17 signaling pathway	4/47	94/8108	0.002064218	0.028011339	0.019098640
hsa05171	Coronavirus disease - COVID-19	6/47	232/8108	0.002069019	0.028011339	0.019098640
hsa01522	Endocrine resistance	4/47	98/8108	0.002404233	0.028797784	0.019634852
hsa04020	Calcium signaling pathway	6/47	240/8108	0.002454357	0.028797784	0.019634852
hsa04660	T cell receptor signaling pathway	4/47	104/8108	0.002983900	0.032333384	0.022045489
hsa04928	Parathyroid hormone synthesis, secretion and action	4/47	106/8108	0.003196652	0.032333384	0.022045489
hsa04659	Th17 cell differentiation	4/47	107/8108	0.003306823	0.032333384	0.022045489
hsa05145	Toxoplasmosis	4/47	112/8108	0.003896789	0.036096573	0.024611300